about
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malariaPlasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy peopleGlobal analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinineChloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in MadagascarWhole genome sequencing of field isolates provides robust characterization of genetic diversity in Plasmodium vivaxPlasmodium vivax Diversity and Population Structure across Four ContinentsContemporary epidemiological overview of malaria in Madagascar: operational utility of reported routine case data for malaria control planningAssessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials.Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programmes using serological markers.Origins of the recent emergence of Plasmodium falciparum pyrimethamine resistance alleles in Madagascar.Viral and atypical bacterial etiology of acute respiratory infections in children under 5 years old living in a rural tropical area of Madagascar.Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains.Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children.In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparumLongitudinal survey of malaria morbidity over 10 years in Saharevo (Madagascar): further lessons for strengthening malaria control.Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar.Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests.Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.
P50
Q21034136-3649D22D-072E-4200-B492-92EC352CF6BCQ24600330-39236C2B-7FBC-4892-A802-12127D507369Q27012884-129A408C-448F-4963-A200-A8CDC5EBC2E2Q28475757-976E87F0-753E-4535-85B9-18E68FFB3E86Q28483522-5C950BA3-D3FB-4818-8870-FCB19E825DD2Q28545982-C4B39928-AE7E-4ADF-A5AD-A7F5224EBEF1Q30151696-2185FE36-90D3-4996-BFF1-F5EA4AB0F38AQ31151729-A42F9584-AD00-45A9-A05F-AA647AD6D60CQ33431658-E14AE0EC-EBCE-43CE-A3FD-AE65C6F045F2Q33876441-DEEC06EA-A510-4120-B32B-E94304DB5D3DQ34389718-E0DFB448-7F94-44D1-BE1E-F323868AC1F2Q35054176-2657D049-BBFA-48F4-BCA8-15EAC545E1D3Q35069313-3731A925-3AC0-41D3-8B60-2491EEB0BDB3Q35338819-C24CE0DB-6768-4E28-AE76-7D57B407EBD6Q35575322-73377576-50BB-42DE-B526-4A2CFDFD0D65Q35689218-AE4F1A44-52A3-4E70-877E-5624ACA6B94BQ35716419-3BA3FBA6-C1C1-4F75-9022-ABD9CA26D833Q35834329-40665B55-DF12-405D-A415-E9712C130C3DQ35917807-04CC1CA9-126B-4E20-B603-3D445B6DFD1EQ36498859-6D85FD69-2EAE-4EA4-BF61-F7E9B13AFDF2Q36993444-2495488B-1485-481A-9F8F-16A1AFBEC2EDQ37409916-4874C5AB-C8ED-42D7-99BD-B624BA6B8A24Q37737972-401EF804-E134-4BFE-B00A-CED3007B37A4
P50
description
onderzoeker
@nl
name
Arsène Ratsimbasoa
@ast
Arsène Ratsimbasoa
@en
Arsène Ratsimbasoa
@es
Arsène Ratsimbasoa
@nl
Arsène Ratsimbasoa
@sl
type
label
Arsène Ratsimbasoa
@ast
Arsène Ratsimbasoa
@en
Arsène Ratsimbasoa
@es
Arsène Ratsimbasoa
@nl
Arsène Ratsimbasoa
@sl
prefLabel
Arsène Ratsimbasoa
@ast
Arsène Ratsimbasoa
@en
Arsène Ratsimbasoa
@es
Arsène Ratsimbasoa
@nl
Arsène Ratsimbasoa
@sl
P106
P21
P31
P569
2000-01-01T00:00:00Z